AU2001250828A1 - Immunogenic ovarian cancer genes - Google Patents

Immunogenic ovarian cancer genes

Info

Publication number
AU2001250828A1
AU2001250828A1 AU2001250828A AU5082801A AU2001250828A1 AU 2001250828 A1 AU2001250828 A1 AU 2001250828A1 AU 2001250828 A AU2001250828 A AU 2001250828A AU 5082801 A AU5082801 A AU 5082801A AU 2001250828 A1 AU2001250828 A1 AU 2001250828A1
Authority
AU
Australia
Prior art keywords
immunogenic
ovarian cancer
cancer genes
genes
ovarian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250828A
Inventor
Honami Naora
Richard Roden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2001250828A1 publication Critical patent/AU2001250828A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
AU2001250828A 2000-03-14 2001-03-14 Immunogenic ovarian cancer genes Abandoned AU2001250828A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18922600P 2000-03-14 2000-03-14
US60/189,226 2000-03-14
US25845200P 2000-12-28 2000-12-28
US60/258,452 2000-12-28
PCT/US2001/007896 WO2001068853A2 (en) 2000-03-14 2001-03-14 Immunogenic ovarian cancer genes

Publications (1)

Publication Number Publication Date
AU2001250828A1 true AU2001250828A1 (en) 2001-09-24

Family

ID=26884912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250828A Abandoned AU2001250828A1 (en) 2000-03-14 2001-03-14 Immunogenic ovarian cancer genes

Country Status (3)

Country Link
US (2) US20020001805A1 (en)
AU (1) AU2001250828A1 (en)
WO (1) WO2001068853A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1451587A4 (en) * 2001-11-09 2006-12-06 Benaroya Res Inst At Virginia Antigen panels and methods of using the same
US20100285031A1 (en) * 2006-05-19 2010-11-11 The Johns Hopkins University Hox Compositions and Methods
US8722351B2 (en) 2009-09-17 2014-05-13 Rush University Medical Center Diagnostic tests for abnormal ovarian conditions
CN117402251B (en) * 2023-12-15 2024-02-23 中国医学科学院基础医学研究所 Antibody for resisting small G protein RBJ and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190931A (en) * 1983-10-20 1993-03-02 The Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US5107065A (en) * 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
US5734022A (en) * 1990-08-01 1998-03-31 The Johns Hopkins University Antibodies to a novel mammalian protein associated with uncontrolled cell division
US5484704A (en) * 1992-11-12 1996-01-16 Baylor College Of Medicine Monoclonal antibody for diagnostic use in ovarian cancer
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
US5840381A (en) * 1996-04-25 1998-11-24 Aicello Chemical Co., Ltd. Corrosion inhibiting laminate sheets and containers
US5858719A (en) * 1997-07-17 1999-01-12 Incyte Pharmaceuticals, Inc. Polynucleotides encoding human ATP binding-cassette transport protein and methods of use
US6140050A (en) * 1998-06-26 2000-10-31 Ludwig Institute For Cancer Research Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
US20050095586A1 (en) 2005-05-05
WO2001068853A3 (en) 2003-01-30
US20020001805A1 (en) 2002-01-03
WO2001068853A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU2002313559A1 (en) Genes
AU2002362454A1 (en) Regulated breast cancer genes
AU2002233230A1 (en) Erythropoietin conjugates
AU2001279319A1 (en) Directional diffuser
AU2001253140A1 (en) Tumor markers in ovarian cancer
AU2002351746A1 (en) Erythropoietin conjugates
AU2002236159A1 (en) Immunogenic complex
HK1083771A1 (en) Anti-neovasculature preparations for cancer
AU2001256320A1 (en) Pigments
AUPR395801A0 (en) Antibodies against cancer
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002360345A1 (en) Prostate cancer genes
AU2001227903A1 (en) Everninomicin biosynthetic genes
AU2002307154A1 (en) Prostate cancer expression profiles
AU2001242342A1 (en) Antiperspirants
AU2001236470A1 (en) Ovarian tumor-associated sequences
AU2002245717A1 (en) Oligonucleotide conjugates
AU2002236517A1 (en) Targetet retoviral vectors for cancer immunotherapy
AU2001240103A1 (en) Reproduction-specific genes
AU2001244358A1 (en) Schizophrenia related genes
AU2001250828A1 (en) Immunogenic ovarian cancer genes
AU2376200A (en) Insulin-synthesis genes
AU2003212826A1 (en) Cancer genes
EP1354948A4 (en) Novel cancer-associated genes
AU2002249823A1 (en) Acne vaccine